Join
Live feed
·
PRReleasevia Quantisnow
Xeris Biopharma Holdings Inc. logo

Xeris Biopharma Reports Record Financial Results for the Second Quarter 2025 and Raises Full Year Revenue Guidance

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track XERS (Xeris Biopharma Holdings Inc.) and more on Quantisnow.